These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Problematic aspects of placebo-controlled double-blind studies with highly effective drugs such as etretinate].
    Author: Schwanitz HJ.
    Journal: Z Hautkr; 1987 May 15; 62(10):785-6, 791. PubMed ID: 3303711.
    Abstract:
    Highly potent drugs should be studied by means of double placebo experiments rather than by semi-blind trials. In semi-blind trials, possible side effects induced by the placebo might not be sufficiently registered, and those induced by the verum cannot be adequately evaluated.
    [Abstract] [Full Text] [Related] [New Search]